These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17023015)

  • 1. Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function.
    Venkatachari NJ; Majumder B; Ayyavoo V
    Virology; 2007 Feb; 358(2):347-56. PubMed ID: 17023015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.
    Majumder B; Janket ML; Schafer EA; Schaubert K; Huang XL; Kan-Mitchell J; Rinaldo CR; Ayyavoo V
    J Virol; 2005 Jul; 79(13):7990-8003. PubMed ID: 15956545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.
    Muthumani K; Choo AY; Hwang DS; Dayes NS; Chattergoon M; Mayilvahanan S; Thieu KP; Buckley PT; Emmanuel J; Premkumar A; Weiner DB
    Mol Ther; 2005 Nov; 12(5):910-21. PubMed ID: 16006193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.
    Kogan M; Deshmane S; Sawaya BE; Gracely EJ; Khalili K; Rappaport J
    J Cell Physiol; 2013 Apr; 228(4):781-90. PubMed ID: 23001849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha.
    Majumder B; Venkatachari NJ; Schafer EA; Janket ML; Ayyavoo V
    J Virol; 2007 Jul; 81(14):7388-99. PubMed ID: 17475642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
    Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
    J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.
    Ayyavoo V; Mahboubi A; Mahalingam S; Ramalingam R; Kudchodkar S; Williams WV; Green DR; Weiner DB
    Nat Med; 1997 Oct; 3(10):1117-23. PubMed ID: 9334723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of HIV-1 viral protein R-induced apoptosis.
    Muthumani K; Choo AY; Hwang DS; Chattergoon MA; Dayes NN; Zhang D; Lee MD; Duvvuri U; Weiner DB
    Biochem Biophys Res Commun; 2003 May; 304(3):583-92. PubMed ID: 12729593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.
    Muthumani K; Hwang DS; Choo AY; Mayilvahanan S; Dayes NS; Thieu KP; Weiner DB
    Int Immunol; 2005 Feb; 17(2):103-16. PubMed ID: 15611322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages.
    Varin A; Decrion AZ; Sabbah E; Quivy V; Sire J; Van Lint C; Roques BP; Aggarwal BB; Herbein G
    J Biol Chem; 2005 Dec; 280(52):42557-67. PubMed ID: 16243842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr and anti-inflammatory activity.
    Muthumani K; Desai BM; Hwang DS; Choo AY; Laddy DJ; Thieu KP; Rao RG; Weiner DB
    DNA Cell Biol; 2004 Apr; 23(4):239-47. PubMed ID: 15142381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.
    Roesch F; Richard L; Rua R; Porrot F; Casartelli N; Schwartz O
    J Virol; 2015 Dec; 89(23):12118-30. PubMed ID: 26401039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
    Zimmerman ES; Sherman MP; Blackett JL; Neidleman JA; Kreis C; Mundt P; Williams SA; Warmerdam M; Kahn J; Hecht FM; Grant RM; de Noronha CM; Weyrich AS; Greene WC; Planelles V
    J Virol; 2006 Nov; 80(21):10407-18. PubMed ID: 16956949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells.
    Muthumani K; Montaner LJ; Ayyavoo V; Weiner DB
    DNA Cell Biol; 2000 Mar; 19(3):179-88. PubMed ID: 10749170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.
    Roux P; Alfieri C; Hrimech M; Cohen EA; Tanner JE
    J Virol; 2000 May; 74(10):4658-65. PubMed ID: 10775602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
    Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
    Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
    Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages.
    Subbramanian RA; Kessous-Elbaz A; Lodge R; Forget J; Yao XJ; Bergeron D; Cohen EA
    J Exp Med; 1998 Apr; 187(7):1103-11. PubMed ID: 9529326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.